Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2008 061 019.5 |
96 | EP file number | EAKZ | 18 15 4616.9 |
97 | EP publication number | EPN | 3342405 |
54 | Designation/title | TI | KONTROLLIERTE FREISETZUNG 25-HYDROXYVITAMIN D |
51 | IPC main class | ICM (ICMV) | A61K 9/48 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/593 (2006.01), A61K 47/06 (2006.01), A61K 47/14 (2006.01), A61K 47/44 (2017.01) |
22 | DE application date | DAT | Apr 25, 2008 |
96 | EP application date | EAT | Apr 25, 2008 |
43 | Date of first publication | OT | Jul 4, 2018 |
| Date of publication of grant | PET | Aug 21, 2019 |
71/73 | Applicant/owner | INH | EirGen Pharma Ltd., Waterford, IE; Opko Renal, LLC, Miami, FL, US |
72 | Inventor | IN | BISHOP, Charles W, Miami, FL Florida 33141, US; Tabash, Samir P, Whitby, Ontario L1R 2Z9, CA; Agudoawu, Sammy A, Mississauga, Ontario L5M 0C5, CA; White, Jay A, Newmarket, Ontario L3X 1T3, CA; CRAWFORD, Keith H, Denver, CO Colorado 80202, US; Messner, Eric J, Lake Forest, IL Illinois 60045, US; Petkovich, P. Martin, Kingston, Ontario K7M 4E8, CA |
74 | Representative | VTR | Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB, 80538 München, DE |
| Address for service | | Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB, 80538 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 913853 P Apr 25, 2007
|
| Due date | FT FG | Apr 30, 2025 Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003342405A1 Searchable text:
EP000003342405A1 Original document:
EP000003342405B1 Searchable text:
EP000003342405B1 |
43 | Date of first publication | EVT | Jul 4, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Jul 4, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 25, 2025 (Show all update days)(Hide all update days)- Feb 25, 2025
- St.36: changed (technical change)
- May 8, 2024; May 10, 2023; May 7, 2022; Apr 7, 2022; May 4, 2021; Aug 13, 2020; Jul 23, 2020; May 6, 2020; Oct 17, 2019; Aug 23, 2019; Aug 1, 2019; Mar 21, 2019
- Historical data not available for this/these date(s)
- Jul 4, 2018
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 6, 2022 |
| Issue number | HN | 19 |
| Year | PJ | 2022 |
| Publication date | VT | May 12, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | EirGen Pharma Ltd., Waterford, IE; Opko Renal, LLC, Miami, FL, US |
71/73 | Previous applicant/owner | INHF | Opko Ireland Global Holdings, Ltd., Dublin, IE, Opko Renal, LLC, Miami, FL, US |
| Date of update of the procedure | REGT | May 7, 2022 |